Logo
x

Search

Subscribe Now

abeona therapeutics

Abeona Therapeutics’ Zevaskyn Receives the US FDA Approval for Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Abeona Therapeutics’ Zevaskyn Receives the US FDA Approval for Recessive Dystrophic Epidermolysis Bullosa (RDEB)

  • April 30, 2025
Abeona Therapeutics Collaborates with Beacon Therapeutics to Develop AAV204 Capsid for Certain Ophthalmology Indications

Abeona Therapeutics Collaborates with Beacon Therapeutics to Develop AAV204 Capsid for Certain Ophthalmology Indications

  • July 12, 2024
Abeona Signs a License and Inventory Purchase Agreements with Taysha for ABO-202 to Treat CLN1 Disease (Infantile Batten disease)

Abeona Signs a License and Inventory Purchase Agreements with Taysha for ABO-202 to Treat CLN1 Disease (Infantile Batten disease)

  • August 17, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.